Indegene Inc., FindMeCure, and European Patients’ Academy on Therapeutic Innovation, EUPATI, joined hands to drive advancement and innovation in treatment practices through greater patient engagement in clinical research. By working with FindMeCure’s feasibility data intelligence platform, Indegene aims to further the cause of delivering affordable patient-centric care.
In line with this, Indegene’s donation to the EUPATI patient education scholarship is another step toward enhancing the overall effectiveness of the clinical development process. The company’s contribution aims to boost patient inclusion efforts, aid successful clinical trials, and help bring innovative treatments to the market with EUPATI’s Patient Expert programme.
EUPATI is a multi-stakeholder public-private partnership launched in 2012. It provides accessible and innovative education, aimed at empowering patients and patient representatives. With patient inclusivity and stakeholder partnership at its core, it enriches the medicines’ R&D process. EUPATI’s commitment to enhancing patient engagement through education is a mission that many leading industry organizations like FindMeCure support.
Indegene is a digital-first, life sciences commercialization company that helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives their team and purpose to enable healthcare organizations to be future-ready.
FindMeCure supports patient education and awareness by helping patients find treatments in development through the clinical trial search platform by the same name and by helping the industry plan clinical trials closer to the patient through a data intelligence platform developed for feasibility.
As part of the shared commitment to enhancing the engagement of patients and patient representatives in medicines research and development, FindMeCure joined the EUPATI Partnership of patient organizations, academia, and industry in 2020. This collaboration is now taking the form of scholarships for patients who want to become patient experts, EUPATI Fellows, and engage with the different stakeholders in the medicine development process. EUPATI has trained over 200 Patient Experts from different disease areas through its Patient Expert Training Programme.
FindMeCure and FindMeCure Foundation are dedicated to bringing research closer to patients. FindMeCure's clinical trial search engine is used on a daily basis by patients searching for clinical trials and so far has served close to a million people worldwide.
FindMeCure has also developed a clinical trial feasibility platform to support the experts in charge of planning trials with accurate and meaningful data. The platform furthers FindMeCure's mission of bringing research closer to patients by helping the industry plan clinical trials with the patient in mind.